About Inocras
Inocras is a company based in San Diego (United States) founded in 2020 by Jeong Seok Lee and Young Seok Ju.. Inocras has raised $52.4 million across 6 funding rounds from investors including Samsung Venture Investment, Big Move Ventures and Dunamu & Partners. Inocras offers products and services including CancerVision, RareVision, and MRDVision. Inocras operates in a competitive market with competitors including Panakeia, Boston Medical Sciences, Nevia Bio, Astrin and Onkolyze, among others.
- Headquarter San Diego, United States
- Founders Jeong Seok Lee, Young Seok Ju
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Inocras Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$52.4 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Samsung Venture Investment
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Inocras
Inocras offers a comprehensive portfolio of products and services, including CancerVision, RareVision, and MRDVision. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Whole genome test for profiling solid tumor cancers and detecting mutations.
Whole genome test for diagnosing rare diseases through comprehensive analysis.
Tumor-informed ctDNA test for minimal residual disease detection in research.
Funding Insights of Inocras
Inocras has successfully raised a total of $52.4M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Seed - Inocras | Valuation |
investors |
|
| Nov, 2023 | Amount | Series B - Inocras | Valuation |
investors |
|
| Apr, 2022 | Amount | Series B - Inocras | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Inocras
Inocras has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Samsung Venture Investment, Big Move Ventures and Dunamu & Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in promising startups.
|
Founded Year | Domain | Location | |
|
Venture capital firm backed by Dunamu
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Inocras
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Inocras
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Inocras Comparisons
Competitors of Inocras
Inocras operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Panakeia, Boston Medical Sciences, Nevia Bio, Astrin and Onkolyze, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| domain | founded_year | HQ Location |
AI-powered colorectal cancer screening system
|
|
| domain | founded_year | HQ Location |
Machine learning-enabled platform for early detection of women-related diseases
|
|
| domain | founded_year | HQ Location |
Early cancer detection is enabled by AI-powered 3D holographic imaging.
|
|
| domain | founded_year | HQ Location |
Ultrasound images are analyzed by AI platform for cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of robotic medical equipment for skin cancer detection
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Inocras
Frequently Asked Questions about Inocras
When was Inocras founded?
Inocras was founded in 2020.
Where is Inocras located?
Inocras is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Inocras?
Jehee Suh is the current CEO of Inocras.
Is Inocras a funded company?
Inocras is a funded company, having raised a total of $52.4M across 6 funding rounds to date. The company's 1st funding round was a Series B of $23M, raised on Jun 01, 2020.
What does Inocras do?
AI-driven platform provides whole genome insights for cancer and rare diseases. It has developed an IP-protected technology and proprietary whole genome insight platform to improve patient diagnosis and treatment by unlocking the full potential of genomic data.
Who are the top competitors of Inocras?
Inocras's top competitors include Panakeia, Boston Medical Sciences and Spotitearly.
What products or services does Inocras offer?
Inocras offers CancerVision, RareVision, and MRDVision.
Who are Inocras's investors?
Inocras has 4 investors. Key investors include Samsung Venture Investment, Big Move Ventures, Dunamu & Partners, and Mss.